"At SDL, our commitment is to support the expansion of world-class biomedical research in Saudi Arabia and throughout the Middle East," commented Khalid S. A. Khabar, Ph.D., Director, Program in BioMolecular Research at KFSH&RC. "Our relationship with ZyGEM, along with access to its leading DNA and RNA extraction technologies, will help SDL to rapidly develop and expand its product base and provide services at the cutting edge of science and technology."
Dr. Khabar continued, "For example, Al Bio is a recent KFSH&RC biotechnology start-up that will soon commence commercial operations, initially under SDL management. Al Bio will provide regional research and medical institutions with a reliable local supply of key laboratory reagents at international quality standards, including kits incorporating ZyGEM's nucleic acid extraction technologies."
ZyGEM's proprietary technology significantly reduces the time and cost of DNA and RNA extractions while simplifying laboratory workflow, minimizing error, reducing the risk of contamination, ensuring sample integrity and facilitating extractions from trace samples. It is easily adaptable for use with off-the-shelf laboratory automation systems. The technology can be specifically formulated for use with a wide range of different sample types without the need for further purification. ZyGEM's technology has been validated for use in highly regulated applications.
ZyGEM Corporation markets nucleic acid extraction solutions based on the company's exclusive collection of microorganisms from extreme environments, with applications in basic research, forensics, clinical diagnostics and agriculture. ZyGEM's MicroLab unit is d
|SOURCE ZyGEM Corp. Ltd.|
Copyright©2010 PR Newswire.
All rights reserved